|
USA-TX-BEAUMONT Κατάλογοι Εταιρεία
|
Εταιρικά Νέα :
- A therapeutic vaccine to cure Hepatitis B - TherVacB
A consortium of leading virologists, immunologists and physicians specialized in treating viral hepatitis, will use a newly designed therapeutic vaccine, TherVacB, as an immunotherapy to cure HBV TherVacB will be evaluated in a clinical trial starting in January 2025 conducted in Europe and in Africa
- Ein therapeutischer Impfstoff zur Heilung von Hepatitis B - TherVacB
Hier finden Sie wissenschaftliche Veröffentlichungen und technische Artikel der TherVacB-Projektpartner Lesen Sie mehr über chronische Hepatitis B, das Virus, Screening und Tests für Hepatitis C und B, therapeutische Impfungen und die Forschung zur Heilung
- About TherVacB: New Concept to fight Chronic Hepatitis B
The mission of TherVacB is to overcome HBV-specific immune tolerance and to restore antiviral B-cell and T-cell responses by therapeutic vaccination to finally cure HBV
- 关于TherVacB：抗击慢性乙型肝炎的新概念
TherVacB为全世界众多的慢性乙肝患者提供了一种新的可负担的治愈方法。 结合已建立的预防性疫苗接种计划，提高对HBV的认知和筛查计划，这种治愈性疗法将有助于实现联合国可持续发展目标3 3：在2030年前与全世界的乙型和丁型肝炎病毒感染作斗争。
- The TherVacB Clinical Trial
Our TherVacB study sites across Europe and in eastern Africa have long-standing experience in clinical hepatitis B research and service TherVacB study physicians are experts in the treatment of viral hepatitis
- The TherVacB Vaccine
The TherVacB Vaccine When will the therapy be available for patients? The clinical trial presented above represents an initial safety and efficacy trial in chronically infected hepatitis B patients
- Una vacuna terapéutica para curar la hepatitis B - TherVacB
Un consorcio de destacados virólogos, inmunólogos y médicos especializados en el tratamiento de la hepatitis vírica, utilizará una vacuna terapéutica de nuevo diseño, TherVacB, como inmunoterapia para curar el VHB
- Un vaccin thérapeutique pour soigner lhépatite B - TherVacB
Un consortium de virologistes, immunologistes et médecins de premier plan spécialisés dans le traitement de l’hépatite virale, utilisera un vaccin thérapeutique de conception nouvelle, TherVacB, comme immunothérapie pour guérir le VHB
- New Hope for Hepatitis B Patients - TherVacB project
Every year, 1 3 million people lose their lives to hepatitis New data from the World Health Organization shows the number of deaths is rising The TherVacB team is not waiting for change Together with researchers from the D-Solve consortium and supporting partners,
- Un vaccino terapeutico per la cura dellepatite B - TherVacB
Un consorzio di importanti virologi, immunologi e medici specializzati nel trattamento dell’epatite virale, utilizzerà un vaccino terapeutico di nuova concezione, TherVacB, come immunoterapia per curare l’HBV
|
|